Prevail Therapeutics Inc (PRVL)

Not featured in screeners

Not featured in screeners

Ticker: PRVL Exchange: NMS

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Top insiders

Company data & Insiders

Download results Settings

Tyto Acquisition Corp

1 purchase — total 771,407,753 USD

Buy 22 Jan 2021

Value US$3,144,794.26 | Price 388.00 | Shares 10,873

Thompson Peter A.

1 purchase — total 14,999,984 USD

Buy 24 Jun 2019

Value US$135,783.38 | Price 26.04 | Shares 68,262

GORDON CARL L

1 purchase — total 14,999,984 USD

Buy 24 Jun 2019

Value US$14,999,984.00 | Price 17.00 | Shares 882,352

ORBIMED ADVISORS LLC

1 purchase — total 14,999,984 USD

Buy 24 Jun 2019

Value US$14,999,984.00 | Price 17.00 | Shares 882,352

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2021-01-22	2021-01-22	B Purchase	Tyto Acquisition Corp Large shareholder	10,873 +12.7% 388.00 US$3,144,794	10,873 +12.7%	388.00	US$3,144,794
2019-06-26	2019-06-24	B Purchase	3.0 Thompson Peter A. Large shareholder	68,262 -44.5% 26.04 US$135,783	68,262 -44.5%	26.04	US$135,783
2019-06-26	2019-06-24	B Purchase	1.5 GORDON CARL L Large shareholder	61,304 +37.4% 62.33 US$2,288,504	61,304 +37.4%	62.33	US$2,288,504
2019-06-26	2019-06-24	B Purchase	2.6 ORBIMED ADVISORS LLC Large shareholder	882,352 +6.8% 17.00 US$14,999,984	882,352 +6.8%	17.00	US$14,999,984

More insider trading research around Prevail Therapeutics Inc